Oxford BioMedica (OTCMKTS:OXBDF) Sees Significant Increase in Short Interest

Posted by Patrick Bannon on Sep 30th, 2026

Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) saw a significant growth in short interest in September. As of September 15th, there was short interest totaling 184,114 shares, a growth of 56.8% from the August 31st total of 117,438 shares. Based on an average daily volume of 4,206 shares, the short-interest ratio is currently 43.8 days. Approximately 0.2% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Oxford BioMedica to a “hold” rating in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Oxford BioMedica currently has a consensus rating of “Hold”.

Check Out Our Latest Analysis on Oxford BioMedica

Oxford BioMedica Price Performance

OTCMKTS OXBDF remained flat at $6.65 during trading hours on Wednesday. 16,707 shares of the company traded hands, compared to its average volume of 1,634. Oxford BioMedica has a fifty-two week low of $5.80 and a fifty-two week high of $12.61. The stock has a fifty day moving average of $7.03 and a two-hundred day moving average of $7.71.

Oxford BioMedica Company Profile

(Get Free Report)

Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.

Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.